BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19317228)

  • 1. [Molecular analyses of the development mechanisms of severe Streptococcus pyogenes infections].
    Terao Y
    Nihon Saikingaku Zasshi; 2008 Dec; 63(2-4):391-8. PubMed ID: 19317228
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of immune evasion by Streptococcus pyogenes].
    Terao Y; Kawabata S
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):982-7. PubMed ID: 21089528
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.
    O'Connor SP; Cleary PP
    J Infect Dis; 1987 Sep; 156(3):495-504. PubMed ID: 3039012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Virulence factors in Streptococcus pyogenes infection].
    Kawabata S
    Nihon Saikingaku Zasshi; 2005 May; 60(2):365-74. PubMed ID: 15966363
    [No Abstract]   [Full Text] [Related]  

  • 5. [Persistence of Streptococcus pyogenes].
    Dmitrieva NF; Timofeev IuM; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):104-9. PubMed ID: 19621829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural heterogeneity of the streptococcal C5a peptidase gene in Streptococcus pyogenes.
    Koroleva IV; Efstratiou A; Suvorov AN
    J Bacteriol; 2002 Nov; 184(22):6384-6. PubMed ID: 12399509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.
    Collin M; Olsén A
    Infect Immun; 2003 Jun; 71(6):2983-92. PubMed ID: 12761074
    [No Abstract]   [Full Text] [Related]  

  • 8. Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes.
    Brouwer S; Cork AJ; Ong CY; Barnett TC; West NP; McIver KS; Walker MJ
    J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genome of group A Streptococcus].
    Ikebe T; Watanabe H
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():665-9. PubMed ID: 12718045
    [No Abstract]   [Full Text] [Related]  

  • 10. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins.
    Berge A; Björck L
    J Biol Chem; 1995 Apr; 270(17):9862-7. PubMed ID: 7730368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pyogenes is essential for evasion from neutrophils.
    Terao Y; Yamaguchi M; Hamada S; Kawabata S
    J Biol Chem; 2006 May; 281(20):14215-23. PubMed ID: 16565520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution genotyping of Streptococcus pyogenes. Application to outbreak studies and population genetics.
    Stanley J; Desai M; Efstratiou A; George R
    Adv Exp Med Biol; 1997; 418():313-6. PubMed ID: 9331659
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonal analysis of five M types causing most disease in New Zealand.
    Martin D; Kakani J; Szeto J
    Adv Exp Med Biol; 1997; 418():331-3. PubMed ID: 9331663
    [No Abstract]   [Full Text] [Related]  

  • 14. Similarity between the group B and A streptococcal C5a peptidase genes.
    Cleary PP; Handley J; Suvorov AN; Podbielski A; Ferrieri P
    Infect Immun; 1992 Oct; 60(10):4239-44. PubMed ID: 1398935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of invasive (septicemic) and non invasive strains of group A streptococci isolated during a one-year national survey in France. The Groupe d'Enquête 1995 sur les Infections Streptococciques.
    Varon E; Havlickova H; Pitman C; Sarr A; Müller-Alouf H; Coignard S; Kriz P; Bouvet A
    Adv Exp Med Biol; 1997; 418():83-5. PubMed ID: 9331605
    [No Abstract]   [Full Text] [Related]  

  • 16. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci.
    Svensson MD; Scaramuzzino DA; Sjöbring U; Olsén A; Frank C; Bessen DE
    Mol Microbiol; 2000 Oct; 38(2):242-53. PubMed ID: 11069651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consideration of cysteine protease activity for serological M-typing of clinical Streptococcus pyogenes isolates.
    Morita M; Ikebe T; Watanabe H
    Microbiol Immunol; 2004; 48(10):779-82. PubMed ID: 15502412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction enzyme analysis (REA) of group A streptococcal (GAS) M-serotypes 1, 3, and 28. A comparison of isolates from severe systemic infections (SSI) and from uncomplicated pharyngitis (UP): epidemiologic and pathogenetic implications.
    Johnson DR; Romana CL; Rehder CD; Dehnbostel J; Kaplan EL
    Adv Exp Med Biol; 1997; 418():221-3. PubMed ID: 9331636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Invasive streptococcal group A infection].
    Riapis LA; Beliakov VD
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):96-100. PubMed ID: 8820691
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of emm gene sequencing and T antigen serology for typing group A streptococcal systemic isolates. Survey of random and outbreak-related isolates.
    Beall B; Facklam R; Hoenes T; Schwartz B
    Adv Exp Med Biol; 1997; 418():307-11. PubMed ID: 9331658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.